Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Psychiatry Reports
Published in: Current Psychiatry Reports 5/2013

01-05-2013 | Schizophrenia and Other Psychotic Disorders (SJ Siegel, Section Editor)

Anxiety as a Core Aspect of Schizophrenia

Authors: Stefano Pallanti, Andrea Cantisani, Giacomo Grassi

Published in: Current Psychiatry Reports | Issue 5/2013

Login to get access

Abstract

The clinical relevance of anxiety disorders in schizophrenia has been neglected for a long time and has only recently become the subject of a systematic investigation, although its consequences may have a very negative impact on the outcome and considerably worsen the trajectory of the disease. This could be originally related to the hierarchical organization of the Diagnostic and Statistical Manual of Mental Disorders (DSM) and to the lack of assessment instruments. In this article, we will review the most recent literature concerning two of the most impairing anxiety disorders in comorbidity with schizophrenia, such as panic disorder and social anxiety disorder, briefly analyze the role of anxiety in the prodromal phase of psychosis and provide suggestions for the clinical assessment.
Literature
1.
Taiminen T, Huttunen J, Heila H, et al. The Schizophrenia Suicide Risk Scale (SSRS): development and initial validation. Schizophr Res. 2001;47:199–213.PubMedCrossRef
2.
Blanchard JJ, Mueser KT, Bellack AS. Anhedonia, positive and negative affect, and social functioning in schizophrenia. Schizophr Bull. 1998;24:413–24.PubMedCrossRef
3.
Bayle FJ, Krebs MO, Epelbaum C, et al. Clinical features of panic attacks in schizophrenia. Eur Psychiatr. 2001;16:349–53.CrossRef
4.
Achim AM, Maziade M, Raymond E, et al. How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association. Schizophr Bull. 2011;37:811–21.PubMedCrossRef
5.
Pallanti S, Quercioli L, Hollander E. Social anxiety in outpatients with schizophrenia: a relevant cause of disability. Am J Psychiatry. 2004;161:53–8.PubMedCrossRef
6.
•• Tiihonen J, Suokas JT, Suvisaari JM, Haukka J, Korhonen P. Polypharmacy with antipsychotics, antidepressants, or benzodiazepines and mortality in schizophrenia. Arch Gen Psychiatry. 2012;69:476–83. This interesting paper, based on the data of a large cohort of patients, highlights the association between benzodiazepine use and increased mortality in schizophrenia.PubMedCrossRef
7.
Buckley PF, Miller BJ, Lehrer DS, et al. Psychiatric comorbidities and schizophrenia. Schizophr Bull. 2009;35:383–402.PubMedCrossRef
8.
Grant BF, Hasin DS, Stinson FS, et al. The epidemiology of DSM-IV panic disorder and agoraphobia in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatr. 2006;67:363–74.CrossRef
9.
Young S, Pfaff D, Lewandowski KE, Ravichandran C. Anxiety disorder comorbidity in bipolar disorder, schizophrenia and schizoaffective disorder. Psychopathology. 2012 Aug 16. [Epub ahead of print].
10.
Rapp EK, White-Ajmani ML, Antonius D. Schizophrenia comorbid with panic disorder: evidence for distinct cognitive profiles. Psychiatr Res. 2012;197:206–2011.CrossRef
11.
Kahn JP, Meyers JR. Treatment of comorbid panic disorder and schizophrenia: evidence for a panic psychosis. Psychiatr Ann. 2000;30:29–33.
12.
Chen CY, Liu CY, Yang YY. Correlation of panic attacks and hostility in chronic schizophrenia. Psychiatr Clin Neurosci. 2001;55:383–7.CrossRef
13.
Goodwin RD, Amador XF, Malaspina D, et al. Anxiety and substance use comorbidity among inpatients with schizophrenia. Schizophr Res. 2003;61:89–95.PubMedCrossRef
14.
Lyons MJ, Huppert J, Toomey R, et al. Lifetime prevalence of mood and anxiety disorders in twin pairs discordant for schizophrenia. Twin Res. 2000;3:28–32.PubMed
15.
• Ulas H, Polat S, Akdele BB, et al. Impact of panic attacks on quality of life among patients with schizophrenia. Progr Neuro Psychopharmacol Biol Psychiatr. 2010;34:1300–5. This paper highlights the importance of recognizing and treating panic symptoms in schizophrenic patients in order to improve the patient’s quality of life.CrossRef
16.
• Savitz AJ, Kahn TA, McGovern KE, Kahn JP. Carbon dioxide induction of panic anxiety in schizophrenia with auditory hallucinations. Psychiatr Res. 2011;189:38–42. This paper highlights the importance of recognizing panic symptoms in schizophrenia and their relevant role in the development of psychotic symptoms.CrossRef
17.
Green AI, Brown ES. Comorbid schizophrenia and substance abuse. J Clin Psychiatr. 2006;67(9):e08.CrossRef
18.
Blanchard JJ, Mueser KT, Bellack AS. Anhedonia, positive and negative affect, and social functioning in schizophrenia. Schizophr Bull. 1998;24(3):413–24.PubMedCrossRef
19.
Gumley A, O’Grady M, Power K, Schwannauer M. Negative beliefs about self and illness: a comparison of individuals with psychosis with or without comorbid social anxiety disorder. Aust N Z J Psychiatr. 2004;38(11):960–4.CrossRef
20.
Penn DL, Hope DA, Spaulding W, Kucera J. Social anxiety in schizophrenia. Schizophr Res. 1994;11(3):277–84.PubMedCrossRef
21.
Lysaker PH, Yanos PT, Outcalt J, et al. Association of stigma, self-esteem, and symptoms with concurrent and prospective assessment of social anxiety in schizophrenia. Clin Schizophr Relat Psychoses. 2010;4(1):41–8.PubMedCrossRef
22.
Hansson L. Determinants of quality of life in people with severe mental illness. Acta Psychiatr Scand. 2006;429:46–50.CrossRef
23.
Hobfoll SE, Walfish S. Coping with a threat to life: a longitudinal study of self concept, social support, and psychological distress. J Soc Clin Psychol. 1984;12(1):87–100.
24.
Birchwood M, Trower P, Brunet K, et al. Social anxiety and the shame of psychosis: a study in first episode psychosis. Behav Res Ther. 2007;45(5):1025–37.PubMedCrossRef
25.
Kumazaki H, Kobayashi H, Niimura H, et al. Lower subjective quality of life and the development of social anxiety symptoms after the discharge of elderly patients with remitted schizophrenia: a 5-year longitudinal study. Compr Psychiatr. 2012;53(7):946–51.CrossRef
26.
Yung AR, McGorry PD. The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophr Bull. 1996;22(2):353–70.PubMedCrossRef
27.
Grassi G, Pellegrini M, Poli L, et al. Obsessive-compulsive disorder and hypochondriasis in schizophrenic patients treated with clozapine versus other atypical antipsychotics. European Neuropsychopharmacology. J Eur Coll Neuropsychopharmacology. 2012;22(Supplement 2):S328.CrossRef
Metadata
Title
Anxiety as a Core Aspect of Schizophrenia
Authors
Stefano Pallanti
Andrea Cantisani
Giacomo Grassi
Publication date
01-05-2013
Publisher
Current Science Inc.
Published in
Current Psychiatry Reports / Issue 5/2013
Print ISSN: 1523-3812
Electronic ISSN: 1535-1645
DOI
https://doi.org/10.1007/s11920-013-0354-7

Other articles of this Issue 5/2013

Current Psychiatry Reports 5/2013 Go to the issue

Anxiety Disorders (DJ Stein, Section Editor)

Recent Advances in Research on Cognition and Emotion in OCD: A Review

Attention-Deficit Disorder (R Bussing, Section Editor)

Antipsychotic and Psychostimulant Drug Combination Therapy in Attention Deficit/Hyperactivity and Disruptive Behavior Disorders: A Systematic Review of Efficacy and Tolerability

Anxiety Disorders (DJ Stein, Section Editor)

Neural, Psychophysiological, and Behavioral Markers of Fear Processing in PTSD: A Review of the Literature

Sexual Disorders (JP Fedoroff, Section Editor)

Pharmacologic Treatment of Sex Offenders With Paraphilic Disorder